The largest database of trusted experimental protocols

129 protocols using novolin r

1

Glucose and Insulin Tolerance Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
A glucose tolerance test (GTT) and insulin tolerance test (ITT) were performed during week 16 and week 17, respectively. * The forward and reverse primer sequences were adapted from van der Heijden et al. (37) For ITT, mice were fasted for 4 h and then injected intraperitoneally with human insulin (1 U/kg body weight; Novolin-R, Novo Nordisk). Values were measured before injection and at 15, 30, 45, 60, 90 and 120 min post-injection.
For GTT, overnight fasted mice were injected with D-glucose (1 g/kg body weight), and blood glucose was measured before injection and at 15, 30, 60 and 120 min post-injection. Glucose levels at indicated time points for ITT and GTT were measured from tail vein blood as described above.
+ Open protocol
+ Expand
2

Age-Dependent Glucose and Insulin Tolerance

Check if the same lab product or an alternative is used in the 5 most similar protocols
For glucose tolerance tests, mice were fasted for 16–17 h, and baseline blood glucose was determined from tail-vein blood (Ascencia Elite XL Glucometer, Bayer Corp and the Accu Check Aviva, Roche). Conscious animals were then challenged with an intraperitoneal (i.p.) injection of glucose (2 g/kg body weight, Sigma-Aldrich), and blood glucose levels were determined at 15, 30, 60, 90, and 120 min post injection. Animals were tested at 10–12 weeks, 20–22 weeks, and 74–78 weeks of age. For insulin tolerance tests, random-fed conscious animals (20–22 weeks and 50–64 weeks of age) were injected with human recombinant insulin (0.75 U/kg body weight, Novolin R, Novo Nordisk). Tail-vein blood samples were taken before and 15, 30, 60, 90, 120, 150 and 180 min post injection.
+ Open protocol
+ Expand
3

Insulin Resistance Assessment in Aged Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
A hyperinsulinemic-euglycemic clamp was used to test the insulin resistance of 56-week-old rats. After anesthetization, two catheters were inserted (one in each femoral vein) for infusion of glucose or insulin (Novolin R; Novo Nordisk, Bagsværd, Denmark) by injection pump (Alaris GH; BD, Franklin Lakes, NJ, USA). A third catheter was inserted into the carotid artery for sampling of blood. Insulin was infused at a constant rate of 20 mU/(kg·min), and arterial blood glucose concentration was maintained at basal fasting level by infusing 25% glucose at variable rates. Under hyperinsulinemic conditions, the steady glucose infusion rate (GIR) required to maintain euglycemia (usually calculated between 60-120?min) is a standard measure of whole-body insulin sensitivity.
+ Open protocol
+ Expand
4

Fasting Glucose and Insulin Testing in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments requiring fasting conditions were performed in the afternoon, 5–6 h following the removal of food at the beginning of the light-cycle for reasons outlined elsewhere70 (link). To ensure fasting conditions, mice were transferred to clean cages containing ISO cotton padding and clean cardboard enrichment tubes. Non-terminal blood was collected via tail snip. Glucose tolerance tests (GTT) were performed following the administration of a filtered dextrose (1 g/kg body mass) solution via IP injection71 (link). Insulin tolerance tests (ITT) were performed following the administration of a filtered insulin (0.75 mU/g body mass; Novolin-R, Novo Nordisk, Bagsvaerd, DK) solution via IP injection72 (link). Blood glucose was measured immediately pre-injection (time 0) and at 15, 30, 45, 60, 90, and 120 min post-injection during the GTT and ITT. The area under curve (AUC) for each animal during both the GTT and ITT were also calculated and presented as the average for each group. Blood glucose levels were determined using Accu-Chek Aviva Plus glucometers (Roche, Basel, CH). Fasting insulin levels from blood collected at baseline and during the terminal harvest were evaluated using a Mouse Ultrasensitive Insulin ELISA from Alpco (Salem, NH, USA).
+ Open protocol
+ Expand
5

Insulin Therapy Management in Pdx1-Hes1 Tg Pigs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pdx1-Hes1 Tg pigs required lifelong administration of exogenous insulin. In humans, the magnitude of disruption of metabolic control by diabetes has been reported, even in young infants and neonates.26 (link) However, studies are often limited by difficulties in obtaining control data. To minimize the risk of hypoglycemia and dead in bed syndrome,27 (link) a minimum dose of insulin is given by the injection of short-acting (Novolin R; Novo Nordisk, Bagsvaerd Denmark) and long-acting insulin analogs (Levemir and Tresiba; Novo Nordisk). Additionally, an insulin pump can be used for continuous subcutaneous insulin delivery as an alternative therapeutic strategy.28 (link) To achieve target glycemic control issues associated with insulin therapy, a continuous subcutaneous insulin infusion (CSII) pump (Medtronic MiniMed 620G Insulin pump; Medtronic Inc, Dublin, Ireland) was used for one Pdx1-Hes1 Tg pig. Because the pump weighed approximately 100 g, we used short-acting and long-acting insulin until the pig reached 7 weeks of age and then used an insulin pump thereafter.
+ Open protocol
+ Expand
6

Insulin-Induced Glucagon Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice (8 weeks) were individually housed and fasted for 6 h. Mice were injected with 0.75 U/kg of insulin (Novolin-R, Novo Nordisk, Princeton, NJ; i.p.). Tail blood was collected in microfuge tubes containing 2 μg/mL aprotinin at the indicated times, spun down at 3000 rpm for 15 min, and plasma glucagon levels were measured with a Glucagon 10 μL ELISA kit (Mercodia).
+ Open protocol
+ Expand
7

Glucose Tolerance and Insulin Sensitivity Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose tolerance was assessed at week 10 using an oral glucose tolerance test (OGTT) after 6 h of fasting. Fasting blood glucose was measured briefly and immediately followed by gavage of glucose solution (2 g/kg) at 15, 30, 60, 90, and 120 min. Insulin sensitivity was assessed at week 11 using the insulin tolerance test (ITT) after 2 h of fasting. Fasting blood glucose was measured briefly and immediately followed by an insulin bolus (0.5 U/kg, Novolin R, Novo Nordisk Bagsvaerd, Denmark) at 15, 30, 45, and 60 min. Blood glucose of the mice in both tests was monitored by tests collected through the tail vein using a Free Lite G-Tech® glucometer (Infopia Co., Ltd; South Korea).
+ Open protocol
+ Expand
8

Insulin Tolerance Test in Lactating Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the insulin tolerance test (ITT), on the 11th day of lactation, all pads were renewed to prevent mice from eating food that had spilled on the pad. After being fasted for 6 h, each dam was weighed and intraperitoneally injected with insulin (100 units/mL, Novolin R, Novo Nordisk, Denmark) at a dose of 0.75 IU/kg body weight. Before injection, the baseline blood glucose concentration was measured and recorded as the concentration at 0 min. After insulin injection, the blood glucose level in the tail vein was measured at 15, 30, 60, 90 and 120 min using a TIDEX glucose analyzer (Sankyo, Tokyo). The rate constant for each ITT (KITT) was calculated using the equation KITT (%/min) = 0.693 / t(1/2), where t(1/2) was calculated from the slope of the plasma glucose concentration 15–120 min after the administration of intravenous insulin.
+ Open protocol
+ Expand
9

Glucose and Insulin Tolerance Tests in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose tolerance tests were performed on mice by intraperitoneal injection of D-glucose (2 g/kg; Sigma-Aldrich) after a 16-hour fast. Insulin tolerance tests were performed on mice injected intraperitoneally with biosynthetic human insulin Novolin R (0.75 U/kg; Novo Nordisk, Bagsvaerd, Denmark) after a 6-hour fast. Blood glucose level was measured using a portable blood glucose meter (Accu-Chek Performa; Roche) at 0, 15, 30, 60, 90, and 120 minutes after injection.
+ Open protocol
+ Expand
10

Glucose and Insulin Tolerance in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 12 and 24 weeks on different diets, mice were fasted overnight, and the blood glucose levels in the tail vein were measured using a handheld glucometer (OneTouch Ultra Easy, LifeScan). For the intraperitoneal glucose tolerance test (IPGTT), glucose concentrations were measured at 15, 30, 60, and 120 min after intraperitoneal injection of a glucose load (2 g/kg). For the intraperitoneal insulin tolerance test (IPITT), mice were fasted for 6 h, after which 0.75 U/kg body weight of insulin (Novolin R, Novo Nordisk, Copenhagen, Denmark) was injected intraperitoneally, and blood glucose levels were determined as above at 0, 15, 30, 60, and 120 min.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!